Insulet Corporation (PODD)

NASDAQ: PODD · Real-Time Price · USD

242.89

+1.05 (0.43%)

At close: Mar 4, 2026, 4:00 PM EST

242.69

-0.20 (-0.08%)

After-hours: Mar 4, 2026, 7:15 PM EST

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
US Omnipod Revenue	1.92B	1.51B
US Omnipod Revenue Growth	27.20%	20.65%
International Omnipod Revenue	754.30M	523.40M
International Omnipod Revenue Growth	44.12%	27.63%
Total Omnipod Revenue	2.67B	2.03B
Total Omnipod Revenue Growth	31.55%	22.37%
Drug Delivery Revenue	34.10M	38.90M
Drug Delivery Revenue Growth	-12.34%	8.06%
Revenue (Other)	-	-
Revenue (Total)	2.71B	2.07B
Revenue (Total) Growth	30.73%	22.07%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
United States Revenue	1.95B	1.55B
United States Revenue Growth	26.20%	20.29%
International Revenue	754.30M	523.40M
International Revenue Growth	44.12%	27.63%
Revenue (Other)	-	-
Revenue (Total)	2.71B	2.07B
Revenue (Total) Growth	30.73%	22.07%

Updated Feb 18, 2026. Data Source: Fiscal.ai.